Both in Pharmaceuticals
Zevra Therapeutics vs ArriVent BioPharma
Over the past year ZVRA returned +0.5% and AVBP returned −26.0%; their daily moves had a correlation of 0.17.
ZVRA +0.5% AVBP −26.0%Growth of $1, one year, split-adjusted
| Metric | ZVRA | AVBP |
|---|---|---|
| Price | $10.26 | $13.02 |
| Market cap | $609.3M | $642.0M |
| Today | +1.58% | −2.47% |
| 1 month | −4.1% | −54.3% |
| 6 months | −3.3% | −56.4% |
| Year to date | +14.5% | −35.3% |
| 1 year | +0.8% | −30.5% |
| Revenue growth (YoY) | +53.3% | — |
| Gross margin | 96.2% | — |
| Net margin | 21.2% | — |
| P/E (TTM) | 10.5× | — |
| Price / sales | 4.5× | — |
| Net cash | $221.6M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 44.3% | 154.4% |
| Short % of float | 10.8% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).